Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05519930 · ClinicalTrials.gov registry record
Pancreatic Cancer Early Detection Registry
A clinical trial, sponsored by Hoag Memorial Hospital Presbyterian.
- Completed
- Registry status
- 326
- Enrollment target
NCT05519930 is a clinical trial that has completed, run by Hoag Memorial Hospital Presbyterian. The registered enrollment target is 326 participants.
The verdict
NCT05519930 has completed, sponsored by Hoag Memorial Hospital Presbyterian.
- COMPLETED
- Registry status
- 326 participants
- Enrollment target
Study Summary
Identify individuals who are at moderate and high risk or predisposed to developing pancreatic cancer with a familial history in which data collected from this study will be used to identify clinical factors associated with early detection of pancreatic cancer.
Interventions
- OTHER hereditary high risk pancreatic cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2016-10-18 |
| Est. Completion | 2023-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05519930
The ClinicalTrials.gov registry entry for NCT05519930 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 326 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hoag Memorial Hospital Presbyterian, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hereditary high risk pancreatic cancer is the first listed.
NCT05519930 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05519930 about?
NCT05519930 is a clinical study titled "Pancreatic Cancer Early Detection Registry". Identify individuals who are at moderate and high risk or predisposed to developing pancreatic cancer with a familial history in which data collected from this study will be used to identify clinical factors associated with early detection of pancreatic cancer.
What is the current status of trial NCT05519930?
This trial is currently completed. The enrollment target is 326 participants. The study started on 2016-10-18. Estimated completion is 2023-07-27.
What interventions are being tested in trial NCT05519930?
The interventions under investigation include: hereditary high risk pancreatic cancer (OTHER).
Who is sponsoring clinical trial NCT05519930?
This trial is sponsored by Hoag Memorial Hospital Presbyterian, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.